AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Medplus Subsidiary Receives Six Drug License Suspension Orders

Medplus Health Services Limited

AI Sentiment Analysis

January 13, 2026, 03:37 PM

Top Queries to Ask About Medplus Health Services Limited

Thinking to buy or sell Medplus Health Services Limited? Ask AI before you act.

Users

Trusted by 5,000+ users

More Details on This News

Med Plus Health Services Limited has announced that its subsidiary, Optival Health Solutions Private Limited, has received six suspension orders for drug licenses of its stores. These suspensions are for varying durations and are located in Karnataka and Telangana.

The Assistant Director, Drugs Control Administration, Bangalore Circle-2, has issued suspension orders for drug licenses of stores located at Ritecure South City Hospital Premises, New Srinagar, Hanumanth Nagar New, and Srinagar Bus Stand, Karnataka. These suspensions are for two days each. The orders were received on January 10, 2026. The alleged violation pertains to Rule 65 of the Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules, 1945. The potential revenue loss for these stores is estimated at ₹0.23 lacs, ₹1.45 lacs, ₹1.08 lacs, and ₹1.69 lacs, respectively.

Additionally, the Assistant Director, Drugs Control Administration, Nalgonda, Telangana, has suspended the drug license for the store located at Thirumalagiri, Telangana, for four days. This order was received on January 12, 2026, and the potential revenue loss is estimated at ₹1.08 lacs.

Furthermore, the Assistant Director, Drugs Control Administration, Patancheruvu, Telangana, has suspended the drug license for the store located at Eidgah Road Krishnareddypet, Telangana, for one day. The potential revenue loss for this store is estimated at ₹0.45 lacs. The company will make this information available on its website and the websites of BSE and NSE.

More News on Medplus Health Services Limited

Analyze Medplus Health Services Limited

Discover more trending news on Prysm

View All